231 related articles for article (PubMed ID: 28994330)
1. Molecular mechanisms and theranostic potential of miRNAs in drug resistance of gastric cancer.
Yang W; Ma J; Zhou W; Cao B; Zhou X; Yang Z; Zhang H; Zhao Q; Fan D; Hong L
Expert Opin Ther Targets; 2017 Nov; 21(11):1063-1075. PubMed ID: 28994330
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-induced drug resistance in gastric cancer.
Dehghanzadeh R; Jadidi-Niaragh F; Gharibi T; Yousefi M
Biomed Pharmacother; 2015 Aug; 74():191-9. PubMed ID: 26349984
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms and clinical implications of miRNAs in drug resistance of esophageal cancer.
Yang W; Ma J; Zhou W; Zhou X; Cao B; Zhang H; Zhao Q; Fan D; Hong L
Expert Rev Gastroenterol Hepatol; 2017 Dec; 11(12):1151-1163. PubMed ID: 28838272
[TBL] [Abstract][Full Text] [Related]
4. Emerging Role of miRNAs in the Drug Resistance of Gastric Cancer.
Riquelme I; Letelier P; Riffo-Campos AL; Brebi P; Roa JC
Int J Mol Sci; 2016 Mar; 17(3):424. PubMed ID: 27011182
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms and clinical implications of miRNAs in drug resistance of colorectal cancer.
Duan L; Yang W; Feng W; Cao L; Wang X; Niu L; Li Y; Zhou W; Zhang Y; Liu J; Zhang H; Zhao Q; Hong L; Fan D
Ther Adv Med Oncol; 2020; 12():1758835920947342. PubMed ID: 32922521
[TBL] [Abstract][Full Text] [Related]
6. Drug resistance-related microRNAs in hematological malignancies: translating basic evidence into therapeutic strategies.
Xie L; Jing R; Qi J; Lin Z; Ju S
Blood Rev; 2015 Jan; 29(1):33-44. PubMed ID: 25263425
[TBL] [Abstract][Full Text] [Related]
7. MiRNA as potential biomarkers and therapeutic targets for gastric cancer.
Shin VY; Chu KM
World J Gastroenterol; 2014 Aug; 20(30):10432-9. PubMed ID: 25132759
[TBL] [Abstract][Full Text] [Related]
8. Drug resistance-related microRNAs in esophageal cancer.
Hong L; Han Y; Lu Q; Zhang H; Zhao Q; Wu K; Fan D
Expert Opin Biol Ther; 2012 Nov; 12(11):1487-94. PubMed ID: 22827640
[TBL] [Abstract][Full Text] [Related]
9. Induction/reversal of drug resistance in gastric cancer by non-coding RNAs (Review).
Chen C; Tang X; Liu Y; Zhu J; Liu J
Int J Oncol; 2019 May; 54(5):1511-1524. PubMed ID: 30896792
[TBL] [Abstract][Full Text] [Related]
10. Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules.
Vo DD; Staedel C; Zehnacker L; Benhida R; Darfeuille F; Duca M
ACS Chem Biol; 2014 Mar; 9(3):711-21. PubMed ID: 24359019
[TBL] [Abstract][Full Text] [Related]
11. Targeting miR-375 in gastric cancer.
Xu Y; Deng Y; Yan X; Zhou T
Expert Opin Ther Targets; 2011 Aug; 15(8):961-72. PubMed ID: 21557705
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of MicroRNA Deregulation and MicroRNA Targets in Gastric Cancer.
Irmak-Yazicioglu MB
Oncol Res Treat; 2016; 39(3):136-9. PubMed ID: 27031864
[TBL] [Abstract][Full Text] [Related]
13. The Roles of microRNAs in Multidrug-Resistance Mechanisms in Gastric Cancer.
Zeng X; Wang HY; Bai SY; Pu K; Wang YP; Zhou YN
Curr Mol Med; 2020; 20(9):667-674. PubMed ID: 32209033
[TBL] [Abstract][Full Text] [Related]
14. Integrated analysis of the miRNA, gene and pathway regulatory network in gastric cancer.
Zhang H; Qu Y; Duan J; Deng T; Liu R; Zhang L; Bai M; Li J; Zhou L; Ning T; Li H; Ge S; Li H; Ying G; Huang D; Ba Y
Oncol Rep; 2016 Feb; 35(2):1135-46. PubMed ID: 26719093
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs in gastrointestinal cancer: prognostic significance and potential role in chemoresistance.
Hong L; Han Y; Yang J; Zhang H; Zhao Q; Wu K; Fan D
Expert Opin Biol Ther; 2014 Aug; 14(8):1103-11. PubMed ID: 24707835
[TBL] [Abstract][Full Text] [Related]
16. An overview of the multifaceted roles of miRNAs in gastric cancer: Spotlight on novel biomarkers and therapeutic targets.
Wu X; Shen J; Xiao Z; Li J; Zhao Y; Zhao Q; Cho CH; Li M
Biochem Pharmacol; 2019 May; 163():425-439. PubMed ID: 30857828
[TBL] [Abstract][Full Text] [Related]
17. Current perspectives toward the identification of key players in gastric cancer microRNA dysregulation.
Ishimoto T; Baba H; Izumi D; Sugihara H; Kurashige J; Iwatsuki M; Tan P
Int J Cancer; 2016 Mar; 138(6):1337-49. PubMed ID: 26041092
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs: promising chemoresistance biomarkers in gastric cancer with diagnostic and therapeutic potential.
Matuszcak C; Haier J; Hummel R; Lindner K
World J Gastroenterol; 2014 Oct; 20(38):13658-66. PubMed ID: 25320504
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs in gastric cancer: Biomarkers and therapeutic targets.
Ghafouri-Fard S; Vafaee R; Shoorei H; Taheri M
Gene; 2020 Oct; 757():144937. PubMed ID: 32640300
[TBL] [Abstract][Full Text] [Related]
20. The challenge of targeted therapies for gastric cancer patients: the beginning of a long journey.
Aprile G; Giampieri R; Bonotto M; Bittoni A; Ongaro E; Cardellino GG; Graziano F; Giuliani F; Fasola G; Cascinu S; Scartozzi M
Expert Opin Investig Drugs; 2014 Jul; 23(7):925-42. PubMed ID: 24806575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
